What is Endotoxin?
Also called: Lipopolysaccharide, LPS, Bacterial endotoxin, Pyrogen
Lipopolysaccharide from the outer membrane of Gram-negative bacteria; a potent trigger of innate immune cells that survives sterilisation and can confound in-vitro assays.
By the APL Research Team · Updated
Endotoxin is lipopolysaccharide (LPS), the molecule that makes up much of the outer membrane of Gram-negative bacteria. It has three parts: lipid A, a core oligosaccharide and the O-antigen. Innate immune cells detect lipid A through the TLR4–MD-2 receptor complex, which signals through NF-κB to switch on pro-inflammatory cytokine production [1]. Endotoxin is heat-stable and remains after the bacteria that shed it are dead, so a solution can be sterile and still carry it.
Why it matters in peptide assays
Endotoxin produces a strong biological signal at concentrations that no purity method would notice, which makes it a classic source of false positives in in-vitro work.
- Commercial reagents can carry it. A screen of reagents used in microglia research found significant LPS in a number of commercial-grade proteins, phospholipids and synthetic peptide preparations, but not in pharmaceutical-grade recombinant proteins. The LPS-binding antibiotic polymyxin B suppressed the activating effect of several commercial preparations [2].
- Whole findings have been traced to it. Endothelial activation attributed to commercial C-reactive protein disappeared after extensive dialysis and was reproduced by azide or LPS alone at the concentrations present in the preparations [3].
- Species changes the picture. Human and mouse TLR4–MD-2 differ in how they recognise lipid A variants [1], so the same contamination can behave differently in human and murine cells.
Assays most exposed are those reading cytokines, NF-κB reporters or activation of monocytes, macrophages, microglia or endothelial cells, including "anti-inflammatory" designs in which LPS is deliberately used as the stimulus and contamination in the test peptide quietly adds to it.
Worked example: endotoxin rides along with the dose
Suppose a peptide (molecular weight 1,500 g/mol) carries an illustrative 1 endotoxin unit (EU) per mg. The endotoxin delivered to the well scales with peptide concentration:
| Peptide in well | Mass concentration | Endotoxin delivered |
|---|---|---|
| 1 µM | 1.5 µg/mL | 0.0015 EU/mL |
| 10 µM | 15 µg/mL | 0.015 EU/mL |
| 100 µM | 150 µg/mL | 0.15 EU/mL |
Because contamination climbs a hundredfold across the range, an artefact can masquerade as a concentration–response curve that appears only at the top doses. The molarity calculator handles the µM-to-µg/mL step, and the dose–response design guide covers the controls that separate a real response from a contaminant.
How it is measured
Limulus or Tachypleus amebocyte lysate (LAL/TAL) assays, prepared from horseshoe crab blood, have long been the standard. Recombinant factor C (rFC) assays correlate closely with them, and because rFC does not respond through the factor G (glucan) pathway, they detect endotoxin more selectively [4]. Results are reported in EU. Each sample type needs a spiked control to show that the peptide itself does not suppress or enhance the reaction.
Common misunderstandings
- "Sterile means endotoxin-free." Sterile filtration removes bacteria, not the LPS they released.
- "99% HPLC purity covers it." Peptide purity by UV does not detect LPS at the levels that activate immune cells. Unless a certificate of analysis reports a measured endotoxin value, treat it as unknown.
- "A heat-inactivation control will expose it." That control works for proteins, whose activity is heat-labile while LPS is not. Many short peptides survive heating too, so polymyxin B or TLR4-blocking controls discriminate better [2].
The immunomodulatory peptides guide covers peptide classes where this confound matters most.
References
- 1.Maeshima N, Fernandez RC. Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol. 2013. PubMed 23408095
- 2.Weinstein JR, Swarts S, Bishop C, et al. Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors. Glia. 2008. PubMed 17910052
- 3.Taylor KE, Giddings JC, van den Berg CW. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2005. PubMed 15802626
- 4.Bolden J, Knutsen C, Levin J, et al. Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review. PDA J Pharm Sci Technol. 2020. PubMed 32817324